ArticleThoracic cancer2020

Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.

Arik Bernard Schulze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.